Evidence map›Paper›PMID 10198078›Full record

ArticlePlant physiology1999

Extragenic suppressors of the Arabidopsis gai mutation alter the dose-response relationship of diverse gibberellin responses.

J Peng, D E Richards, T Moritz, A Caño-Delgado, N P Harberd

Open access · bronzeAbstract read
In one paragraph

Article in Plant physiology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
11.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Review
  3. A Suppressor Mutation Partially Reverts theFrontiers in plant science · 2019
    Article
  4. Article
  5. Redox regulation of plant development.Antioxidants & redox signaling · 2014
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

J PengDepartment of Molecular Genetics, John Innes Centre, Colney Lane, Norwich NR4 7UJ, United Kingdom.
D E Richards
T Moritz
A Caño-Delgado
N P Harberd
John Innes Centre · GBSwedish University of Agricultural Sciences · SE

Funding

Biotechnology and Biological Sciences Research Council BBS/E/J/00000583
6 · The paper itself

Abstract

Active gibberellins (GAs) are endogenous factors that regulate plant growth and development in a dose-dependent fashion. Mutant plants that are GA deficient, or exhibit reduced GA responses, display a characteristic dwarf phenotype. Extragenic suppressor analysis has resulted in the isolation of Arabidopsis mutations, which partially suppress the dwarf phenotype conferred by GA deficiency and reduced GA-response mutations. Here we describe detailed studies of the effects of two of these suppressors, spy-7 and gar2-1, on several different GA-responsive growth processes (seed germination, vegetative growth, stem elongation, chlorophyll accumulation, and flowering) and on the in planta amounts of active and inactive GA species. The results of these experiments show that spy-7 and gar2-1 affect the GA dose-response relationship for a wide range of GA responses and suggest that all GA-regulated processes are controlled through a negatively acting GA-signaling pathway.

Indexed as

Arabidopsis ProteinsMutationRepressor ProteinsArabidopsisDose-Response Relationship, DrugGenes, PlantGenes, SuppressorGibberellinsPhenotypePlant ProteinsSignal TransductionArabidopsis ProteinsGAI protein, ArabidopsisGibberellinsPlant ProteinsRepressor ProteinsSPY protein, Arabidopsis

Identifiers

PMID10198078
PMCPMC32004
OpenAlexW2130722077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.